493 related articles for article (PubMed ID: 35880178)
1. Peroxisome Proliferator-Activated Receptors Regulate Hepatic Immunity and Assist in the Treatment of Primary Biliary Cholangitis.
Wang C; Shi Y; Wang X; Ma H; Liu Q; Gao Y; Niu J
Front Immunol; 2022; 13():940688. PubMed ID: 35880178
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of fibrates in the treatment of primary biliary cholangitis: a meta-analysis.
Zhang H; Li S; Feng Y; Zhang Q; Xie B
Clin Exp Med; 2023 Sep; 23(5):1741-1749. PubMed ID: 36318376
[TBL] [Abstract][Full Text] [Related]
3. Combination of fibrates with obeticholic acid is able to normalise biochemical liver tests in patients with difficult-to-treat primary biliary cholangitis.
Soret PA; Lam L; Carrat F; Smets L; Berg T; Carbone M; Invernizzi P; Leroy V; Trivedi P; Cazzagon N; Weiler-Normann C; Alric L; Rosa-Hezode I; Heurgué A; Cervoni JP; Dumortier J; Potier P; Roux O; Silvain C; Bureau C; Anty R; Larrey D; Levy C; Pares A; Schramm C; Nevens F; Chazouillères O; Corpechot C
Aliment Pharmacol Ther; 2021 May; 53(10):1138-1146. PubMed ID: 33764590
[TBL] [Abstract][Full Text] [Related]
4. Fibrates for Primary Biliary Cholangitis: What's All the Hype?
Levy C
Ann Hepatol; 2017; 16(5):704-706. PubMed ID: 28809729
[TBL] [Abstract][Full Text] [Related]
5. Current Treatment Options for Primary Biliary Cholangitis.
Wong KA; Bahar R; Liu CH; Bowlus CL
Clin Liver Dis; 2018 Aug; 22(3):481-500. PubMed ID: 30259848
[TBL] [Abstract][Full Text] [Related]
6. Treatment of Primary Biliary Cholangitis including Transplantation.
Muzahim Y; Wakil A; Bassi M; Pyrsopoulos N
Clin Liver Dis; 2024 Feb; 28(1):103-114. PubMed ID: 37945152
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and Safety of Elafibranor in Primary Biliary Cholangitis.
Kowdley KV; Bowlus CL; Levy C; Akarca US; Alvares-da-Silva MR; Andreone P; Arrese M; Corpechot C; Francque SM; Heneghan MA; Invernizzi P; Jones D; Kruger FC; Lawitz E; Mayo MJ; Shiffman ML; Swain MG; Valera JM; Vargas V; Vierling JM; Villamil A; Addy C; Dietrich J; Germain JM; Mazain S; Rafailovic D; Taddé B; Miller B; Shu J; Zein CO; Schattenberg JM; ;
N Engl J Med; 2024 Feb; 390(9):795-805. PubMed ID: 37962077
[TBL] [Abstract][Full Text] [Related]
8. [Diagnosis and Treatment of Primary Biliary Cholangitis].
Kim KA
Korean J Gastroenterol; 2023 Feb; 81(2):86-90. PubMed ID: 36824036
[TBL] [Abstract][Full Text] [Related]
9. Treatment in primary biliary cholangitis: Beyond ursodeoxycholic acid.
van Hooff MC; Werner E; van der Meer AJ
Eur J Intern Med; 2024 Jun; 124():14-21. PubMed ID: 38307734
[TBL] [Abstract][Full Text] [Related]
10. Treatment of primary biliary cholangitis ursodeoxycholic acid non-responders: A systematic review.
Suraweera D; Rahal H; Jimenez M; Viramontes M; Choi G; Saab S
Liver Int; 2017 Dec; 37(12):1877-1886. PubMed ID: 28517369
[TBL] [Abstract][Full Text] [Related]
11. Additional fibrate treatment in UDCA-refractory PBC patients.
Chung SW; Lee JH; Kim MA; Leem G; Kim SW; Chang Y; Lee HY; Yoon JS; Park JY; Lee YB; Cho EJ; Yu SJ; Kim YJ; Yoon JH
Liver Int; 2019 Sep; 39(9):1776-1785. PubMed ID: 31162879
[TBL] [Abstract][Full Text] [Related]
12. UK-Wide Multicenter Evaluation of Second-line Therapies in Primary Biliary Cholangitis.
Abbas N; Culver EL; Thorburn D; Halliday N; Crothers H; Dyson JK; Phaw A; Aspinall R; Khakoo SI; Kallis Y; Smith B; Patanwala I; McCune A; Chimakurthi CR; Hegade V; Orrell M; Jones R; Mells G; Thain C; Thain RM; Jones D; Hirschfield G; Trivedi PJ
Clin Gastroenterol Hepatol; 2023 Jun; 21(6):1561-1570.e13. PubMed ID: 35961518
[TBL] [Abstract][Full Text] [Related]
13. Management of Primary Biliary Cholangitis: Current Treatment and Future Perspectives.
Barba Bernal R; Ferrigno B; Medina Morales E; Castro CM; Goyes D; Trivedi H; Patwardhan VR; Bonder A
Turk J Gastroenterol; 2023 Feb; 34(2):89-100. PubMed ID: 36843300
[TBL] [Abstract][Full Text] [Related]
14. Effects of Bezafibrate on Outcome and Pruritus in Primary Biliary Cholangitis With Suboptimal Ursodeoxycholic Acid Response.
Reig A; Sesé P; Parés A
Am J Gastroenterol; 2018 Jan; 113(1):49-55. PubMed ID: 29016567
[TBL] [Abstract][Full Text] [Related]
15. Primary sclerosing cholangitis response to the combination of fibrates with ursodeoxycholic acid: French-Spanish experience.
Lemoinne S; Pares A; Reig A; Ben Belkacem K; Kemgang Fankem AD; Gaouar F; Poupon R; Housset C; Corpechot C; Chazouillères O
Clin Res Hepatol Gastroenterol; 2018 Dec; 42(6):521-528. PubMed ID: 30100231
[TBL] [Abstract][Full Text] [Related]
16. Obeticholic acid for the treatment of primary biliary cholangitis.
Ali AH; Lindor KD
Expert Opin Pharmacother; 2016 Sep; 17(13):1809-15. PubMed ID: 27468093
[TBL] [Abstract][Full Text] [Related]
17. Safety of fibrates in cholestatic liver diseases.
Carrion AF; Lindor KD; Levy C
Liver Int; 2021 Jun; 41(6):1335-1343. PubMed ID: 33751787
[TBL] [Abstract][Full Text] [Related]
18. Novel Aspects in the Management of Cholestatic Liver Diseases.
Chazouillères O
Dig Dis; 2016; 34(4):340-6. PubMed ID: 27170387
[TBL] [Abstract][Full Text] [Related]
19. Primary biliary cholangitis: pathogenesis and therapeutic opportunities.
Gulamhusein AF; Hirschfield GM
Nat Rev Gastroenterol Hepatol; 2020 Feb; 17(2):93-110. PubMed ID: 31819247
[TBL] [Abstract][Full Text] [Related]
20. Novel Treatment Strategies for Primary Biliary Cholangitis.
Parés A
Semin Liver Dis; 2017 Feb; 37(1):60-72. PubMed ID: 28201850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]